Cargando…
Everolimus‐facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2‐year results from the subgroup analysis of the TRANSFORM study
OBJECTIVE: We analyzed the efficacy and safety of an everolimus with reduced‐exposure calcineurin inhibitor (EVR+rCNI) versus mycophenolic acid with standard‐exposure CNI (MPA+sCNI) regimen in Asian patients from the TRANSFORM study. METHODS: In this 24‐month, open‐label study, de novo kidney transp...
Autores principales: | Watarai, Yoshihiko, Danguilan, Romina, Casasola, Concesa, Chang, Shen‐Shin, Ruangkanchanasetr, Prajej, Kee, Terence, Wong, Hin Seng, Kenmochi, Takashi, Amante, Angel Joaquin, Shu, Kuo‐Hsiung, Ingsathit, Atiporn, Bernhardt, Peter, Hernandez‐Gutierrez, Maria Pilar, Han, Duck Jong, Kim, Myoung Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255374/ https://www.ncbi.nlm.nih.gov/pubmed/34216395 http://dx.doi.org/10.1111/ctr.14415 |
Ejemplares similares
-
Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
por: Satirapoj, Bancha, et al.
Publicado: (2015) -
Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
por: Ivulich, Steven, et al.
Publicado: (2023) -
Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study
por: Kaewput, Wisit, et al.
Publicado: (2019) -
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
por: Bergh, Niklas, et al.
Publicado: (2020) -
Epidemiology of extended-spectrum β-lactamase–producing Enterobacterales infection in kidney transplant recipients
por: Promsuwan, Oranuch, et al.
Publicado: (2023)